Research Center Launched to Study HIV-Related Brain Injury
A new $3 million grant supports research into how HIV affects the brain to help improve future diagnosis and care.
Updated on Sept. 29, 2026 in Alzheimer’s
Live Poll
Should federal grants prioritize funding research centers to identify biological markers for complex diseases?
Weill Cornell Medicine and Rutgers Health have established the New York-New Jersey Center for Actionable NeuroHIV Biomarkers following a $3 million federal grant. This initiative aims to enhance research capacity for understanding how HIV impacts brain health.
Why it matters
The center addresses the ongoing clinical challenge of HIV persisting in the brain, which can lead to cognitive, behavioral, or movement issues. Because effective therapies to reduce this specific neurological damage are currently limited, this work seeks to identify markers for better care.
The National Institute of Mental Health awarded a $3 million grant to support a new research center over a four-year period. While this funding provides infrastructure and training for investigators, it does not support direct patient treatment.
The players
National Institute of Mental Health
A federal agency that leads national research into mental health and neurological conditions.
Weill Cornell Medicine
A medical research institution in New York focused on advancing clinical care and biomedical science.
Rutgers Health
An academic health system in New Jersey that integrates medical research, education, and clinical practice.
The details
Researchers at the new center will utilize human-tissue culture techniques, including the use of organoids, to observe how the virus interacts with and damages brain cells. The facility will also provide investigators with shared access to molecular and computational tools designed to study the central nervous system in greater detail.
Timeline
The federal grant provides funding for a four-year period.
Health Landscape
This center operates within the broader scope of NIH-funded research into chronic viral reservoirs and their long-term neurological impacts. It represents an effort to bridge the gap between basic laboratory research and the development of future diagnostic therapies.
This research initiative focuses on building laboratory capacity and is not currently recruiting patients for treatment or clinical trials. Patients concerned about neurological or cognitive symptoms should continue to consult their primary care physician or a neurologist for a personalized evaluation.
The takeaway
HIV can impact brain function long after diagnosis, making it important to track changes in memory, behavior, or movement. If you notice persistent cognitive or neurological concerns, discuss them with your doctor to rule out complications and receive appropriate monitoring.
Further reading
For more information on how researchers track cognitive changes and neurological health, visit Alzheimer’s.
Source note: This article includes information reported by Fingerlakes1.
Live Poll
Should federal grants prioritize funding research centers to identify biological markers for complex diseases?
